Triple

T5932232
Position Surface form Disambiguated ID Type / Status
Subject ICH E131963 entity
Predicate notableGuideline P66981 FINISHED
Object ICH Q1 Stability Testing of New Drug Substances and Products
ICH Q1 Stability Testing of New Drug Substances and Products is an international regulatory guideline that defines the scientific principles and study requirements for assessing the stability, shelf life, and storage conditions of new pharmaceutical substances and finished products.
E555140 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ICH Q1 Stability Testing of New Drug Substances and Products | Statement: [ICH, notableGuideline, ICH Q1 Stability Testing of New Drug Substances and Products]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: ICH Q1 Stability Testing of New Drug Substances and Products
Context triple: [ICH, notableGuideline, ICH Q1 Stability Testing of New Drug Substances and Products]
  • A. ICH Q8 Pharmaceutical Development
    ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
  • B. ICH Q10 Pharmaceutical Quality System
    ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
  • C. Certificates of Suitability to the monographs of the European Pharmacopoeia
    Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
  • D. Office of Pharmaceutical Quality
    The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
  • E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: ICH Q1 Stability Testing of New Drug Substances and Products
Triple: [ICH, notableGuideline, ICH Q1 Stability Testing of New Drug Substances and Products]
Generated description
ICH Q1 Stability Testing of New Drug Substances and Products is an international regulatory guideline that defines the scientific principles and study requirements for assessing the stability, shelf life, and storage conditions of new pharmaceutical substances and finished products.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: ICH Q1 Stability Testing of New Drug Substances and Products
Target entity description: ICH Q1 Stability Testing of New Drug Substances and Products is an international regulatory guideline that defines the scientific principles and study requirements for assessing the stability, shelf life, and storage conditions of new pharmaceutical substances and finished products.
  • A. ICH Q8 Pharmaceutical Development
    ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
  • B. ICH Q10 Pharmaceutical Quality System
    ICH Q10 Pharmaceutical Quality System is an international guideline that establishes a comprehensive, lifecycle-based framework for pharmaceutical quality management to ensure consistent product quality and regulatory compliance.
  • C. Certificates of Suitability to the monographs of the European Pharmacopoeia
    Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
  • D. Office of Pharmaceutical Quality
    The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
  • E. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
    The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: notableGuideline
Context triple: [ICH, notableGuideline, ICH Q1 Stability Testing of New Drug Substances and Products]
  • A. notableStandard
    Indicates that one entity is a widely recognized or influential standard that the other entity is associated with or exemplifies.
  • B. notableRule
    Indicates that a rule or regulation is particularly significant, prominent, or noteworthy within a given context.
  • C. notableCriterion
    Indicates that something is distinguished or recognized based on a particular standard, measure, or qualifying condition.
  • D. notableProvision
    Indicates that one entity is a significant or noteworthy clause, term, or condition contained within another entity, such as a document, agreement, or law.
  • E. notableSafety
    Indicates that an entity is recognized for having significant safety characteristics, performance, or impact relative to others.
  • F. None of above. chosen

Provenance (7 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085b75e88190a632f9691f9da48b completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c03f26f51881908cc253fe5775a1fc completed March 22, 2026, 7:12 p.m.
NED1 Entity disambiguation (via context triple) batch_69c0c064d2a4819096085668182cfde1 completed March 23, 2026, 4:24 a.m.
NEDg Description generation batch_69c0c109b3288190928dc4539a2872c2 completed March 23, 2026, 4:26 a.m.
NED2 Entity disambiguation (via description) batch_69c0c1f6fe60819080a00976740b6a9c completed March 23, 2026, 4:30 a.m.
PD Predicate disambiguation batch_69c03355caf08190b960563a1aed23f9 completed March 22, 2026, 6:22 p.m.
PDg Predicate description generation batch_69c03f23dd20819089dbf0de0d913602 completed March 22, 2026, 7:12 p.m.
Created at: March 22, 2026, 4 p.m.